Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Oncotarget|June 14, 2019
Comparative genomic analysis of driver mutations in matched primary and recurrent meningiomasJoshua Loewenstern, John Rutland, Corey Gill, et al.Journal of Clinical Medicine|October 29, 2025
Immunohistochemical Comparison of Dopamine-2 Receptor Expression in Resistant and Non-Resistant ProlactinomasIlana Ramer Bass, Julia Ferreira de Carvalho, Melissa Umphlett, et al.Journal of Neuropathology and Experimental Neurology|August 7, 2023
CDKN2A mutations have equivalent prognostic significance to homozygous deletion in IDH-mutant astrocytomaRaquel T Yokoda, William S Cobb, Raymund L Yong, et al.World Neurosurgery|December 28, 2018
Biopsy During Minimally Invasive Intracerebral Hemorrhage Clot EvacuationAdam C Lieber, Ian T McNeill, Jacopo Scaggiante, et al.Neuro-Oncology Advances|August 9, 2023
Mismatch repair protein mutations in isocitrate dehydrogenase (IDH)-mutant astrocytoma and IDH-wild-type glioblastomaTimothy E Richardson, Raquel T Yokoda, Omid Rashidipour, et al.Journal of Cancer Research and Clinical Oncology|March 14, 2021
SWI/SNF chromatin remodeling complex alterations in meningiomaCorey M Gill, Joshua Loewenstern, John W Rutland, et al.Cancer Immunology, Immunotherapy : CII|July 15, 2020
NF2 mutation status and tumor mutational burden correlate with immune cell infiltration in meningiomasJohn W Rutland, Corey M Gill, Joshua Loewenstern, et al.British Journal of Neurosurgery|April 25, 2023
<i>NF2</i> mutation associated with accelerated time to recurrence for older patients with atypical meningiomasJonathan T Dullea, Danielle Chaluts, Vikram Vasan, et al.Neuroradiology|August 14, 2020
Peritumoral edema correlates with mutational burden in meningiomasCorey M Gill, Joshua Loewenstern, John W Rutland, et al.Neuro-Oncology Advances|June 16, 2023
The prognostic impact of subclonal IDH1 mutation in grade 2-4 astrocytomasMeenakshi Vij, Raquel T Yokoda, Omid Rashidipour, et al.Pageof 4